BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37300670)

  • 1. High Expression of TIMM17B Is a Potential Diagnostic and Prognostic Marker of Breast Cancer.
    Mingting Duan ; Yun Ren ; Jiwen Zhang ; Tingting Zhang ; Yanhong Wang ; Hongyan Jia
    Cell Mol Biol (Noisy-le-grand); 2023 Mar; 69(3):169-176. PubMed ID: 37300670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of TIMM8A is correlated with prognosis and immune regulation in BC.
    Zhang Y; Lin L; Wu Y; Bing P; Zhou J; Yu W
    Front Oncol; 2022; 12():922178. PubMed ID: 36248992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltrates.
    Fang Y; Liu J; Zhang Q; She C; Zheng R; Zhang R; Chen Z; Chen C; Wu J
    World J Surg Oncol; 2022 Jun; 20(1):211. PubMed ID: 35729567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
    Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
    Front Immunol; 2022; 13():891175. PubMed ID: 35990668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive
    Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
    Front Immunol; 2022; 13():931906. PubMed ID: 35958598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
    Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
    BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Aging-Related Prognostic lncRNA Signature Correlated with Immune Cell Infiltration and Response to Immunotherapy in Breast Cancer.
    Liu Z; Ren C; Cai J; Yin B; Yuan J; Ding R; Ming W; Sun Y; Li Y
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer.
    Wang Z; Liu H; Gong Y; Cheng Y
    Eur J Med Res; 2022 Dec; 27(1):317. PubMed ID: 36581948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Analysis of Ferroptosis-Related LncRNAs in Breast Cancer Patients Reveals Prognostic Value and Relationship With Tumor Immune Microenvironment.
    Xu Z; Jiang S; Ma J; Tang D; Yan C; Fang K
    Front Surg; 2021; 8():742360. PubMed ID: 34671639
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification and development of an independent immune-related genes prognostic model for breast cancer.
    Chen L; Dong Y; Pan Y; Zhang Y; Liu P; Wang J; Chen C; Lu J; Yu Y; Deng R
    BMC Cancer; 2021 Mar; 21(1):329. PubMed ID: 33785008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer.
    Tang W; Xu F; Zhao M; Zhang S
    BMC Cancer; 2021 Oct; 21(1):1160. PubMed ID: 34715817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients.
    Chen M; Nie Z; Li Y; Gao Y; Wen X; Cao H; Zhang S
    Front Cell Dev Biol; 2021; 9():699804. PubMed ID: 34869304
    [No Abstract]   [Full Text] [Related]  

  • 13. Screening of the novel immune-suppressive biomarkers of TMED family and whether knockdown of TMED2/3/4/9 inhibits cell migration and invasion in breast cancer.
    Fang Z; Song YX; Wo GQ; Zhou HL; Li L; Yang SY; Chen X; Zhang J; Tang JH
    Ann Transl Med; 2022 Dec; 10(23):1280. PubMed ID: 36618780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new prognostic factor of breast cancer: High carboxyl ester lipase expression related to poor survival.
    Cui Y; Jiao Y; Wang K; He M; Yang Z
    Cancer Genet; 2019 Nov; 239():54-61. PubMed ID: 31561066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced Expression of KRT17 Predicts Poor Prognosis in HER2
    Tang S; Liu W; Yong L; Liu D; Lin X; Huang Y; Wang H; Cai F
    Biomolecules; 2022 Aug; 12(9):. PubMed ID: 36139022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance for diagnosis and prognosis of POP1 and its potential role in breast cancer: a comprehensive analysis based on multiple databases.
    He X; Wang J; Yu H; Lv W; Wang Y; Zhang Q; Liu Z; Wu Y
    Aging (Albany NY); 2022 Sep; 14(17):6936-6956. PubMed ID: 36084948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a ferroptosis-related eight gene signature for predicting the prognosis and immune infiltration of thyroid cancer.
    Ren X; Du H; Cheng W; Wang Y; Xu Y; Yan S; Gao Y
    Front Endocrinol (Lausanne); 2022; 13():997873. PubMed ID: 36407322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of DRP1 as a prognostic factor correlated with immune infiltration in breast cancer.
    Liu B; Fan Y; Song Z; Han B; Meng Y; Cao P; Tan K
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107078. PubMed ID: 33049497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KIF2C is a prognostic biomarker associated with immune cell infiltration in breast cancer.
    Liu S; Ye Z; Xue VW; Sun Q; Li H; Lu D
    BMC Cancer; 2023 Apr; 23(1):307. PubMed ID: 37016301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Framework to Predict Breast Cancer Prognosis Using Immune-Associated LncRNAs.
    Huang Z; Xiao C; Zhang F; Zhou Z; Yu L; Ye C; Huang W; Li N
    Front Genet; 2020; 11():634195. PubMed ID: 33584821
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.